MichaelKasperkiewiczMD

PubMed

• Risk of de novo bullous pemphigoid and pemphigus following transplantation: A global wide-scale cohort study.
  Michael Kasperkiewicz, Jerzy W Kupiec-Weglinski, Binh T Ngo, Khalaf Kridin, Ralf J Ludwig> ;Journal of the European Academy of Dermatology and Venereology. 2024 Mar 1
• Risk of comorbid autoimmune diseases in patients with immunobullous disorders: A global large-scale cohort study.
  Michael Kasperkiewicz, Artem Vorobyev, Katja Bieber, Khalaf Kridin, Ralf J Ludwig> ;Journal of the American Academy of Dermatology. 2023 Dec 1
• 3 citations
  COVID-19 and autoimmune bullous diseases: Lessons learned.
  Michael Kasperkiewicz, David T Woodley> ;Autoimmunity Reviews. 2023 Apr 1
• Differences in the detection of circulating Hsp90 alpha between patients with atopic dermatitis and dermatitis herpetiformis.
  Sitko, K., Kárpáti, S., Węgrzyn, G., Mincewicz, G., Trzeciak, M., Tukaj, S., Kasperkiewicz, M.> ;Frontiers in Medicine. 2023 Jan 1
• A life for autoimmune blistering diseases: in memoriam Detlef Zillikens.
  Hundt, J., Sadik, C., van Beek, N., Busch, H., Caux, F., Goebeler, M., Hammers, C., Hartmann, K., Hashimoto, T., Ibrahim, S., Kasperkiewicz, M., Murrell, D., Recke, A....> ;Frontiers in Immunology. 2023 Jan 1
• 2 citations
  A cross-sectional study of dermatologists' attitudes towards COVID-19 vaccination in patients with immunobullous diseases.
  Michael Kasperkiewicz, Rebecca Strong, Marc Yale, Patrick Dunn, David T Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2023 Feb 1
• 2 citations
  Role of the International Pemphigus and Pemphigoid Foundation during the COVID-19 pandemic.
  M Kasperkiewicz, R Strong, M Yale, P Dunn, D T Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2022 Sep 1
• 3 citations
  Rituximab in immunobullous disorders during the COVID-19 pandemic: A systematic review of observational studies.
  Michael Kasperkiewicz, David T Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2023 Jan 1
• 3 citations
  Safety of the COVID-19 vaccine booster in patients with immunobullous diseases: A cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
  Michael Kasperkiewicz, Rebecca Strong, Marc Yale, Patrick Dunn, David T Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2023 Jan 1
• Bullous pemphigoid anti-BP180-NC16A autoantibody reactivity in healthy individuals is associated with marked hypovitaminosis D and Th2-like cytokine predominance.
  Stefan Tukaj, Katja Bieber, Wiebke Prüßmann, Jasper N Prüßmann, Enno Schmidt, Detlef Zillikens, Ralf J Ludwig, Michael Kasperkiewicz> ;Archives of Dermatological Research. 2023 Dec 1
• 9 citations
  Association between vaccination and immunobullous disorders: a brief, updated systematic review with focus on COVID-19.
  M Kasperkiewicz, D T Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2022 Jul 1
• 6 citations
  Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event.
  Michael Kasperkiewicz> ;Journal of the European Academy of Dermatology and Venereology. 2022 Sep 1
• 2 citations
  Targeting heat shock proteins 90 and 70: A promising remedy for both autoimmune bullous diseases and COVID-19.
  Michael Kasperkiewicz, Stefan Tukaj> ;Frontiers in Immunology. 2022 Jan 1
• 1 citations
  Commentary: Bullous pemphigoid associated with COVID-19 vaccines: An Italian multicenter study.
  Michael Kasperkiewicz, Stefan Tukaj> ;Frontiers in Medicine. 2022 Jan 1
• 2 citations
  Pathological Relevance of Anti-Hsp70 IgG Autoantibodies in Epidermolysis Bullosa Acquisita.
  Stefan Tukaj, Jagoda Mantej, Krzysztof Sitko, Detlef Zillikens, Ralf J Ludwig, Katja Bieber, Michael Kasperkiewicz> ;Frontiers in Immunology. 2022 Jan 1
• 12 citations
  COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation
  Michael Kasperkiewicz, R Strong, K Mead, M. Yale, Detlef Zillikens, David T. Woodley, Andreas Recke> ;The British Journal of Dermatology. 2021 Nov 29
• 5 citations
  Evidence for a role of extracellular heat shock protein 70 in epidermolysis bullosa acquisita.
  Stefan Tukaj, Jagoda Mantej, Krzysztof Sitko, Marta Bednarek, Detlef Zillikens, Ralf Ludwig, Katja Bieber, Michael Kasperkiewicz> ;Experimental Dermatology. 2021 Nov 6
• 7 citations
  Prevalence and presumptive triggers of localized bullous pemphigoid.
  Sascha Ständer, Michael Kasperkiewicz, Diamant Thaçi, Enno Schmidt, Detlef Zillikens, Artem Vorobyev, Ralf Ludwig> ;The Journal of Dermatology. 2021 May 17
• 19 citations
  Association between vaccination and autoimmune bullous diseases: a systematic review
  Michael Kasperkiewicz, David T. Woodley> ;Journal of the American Academy of Dermatology. 2021 Apr 24
• 10 citations
  COVID-19 pandemic and autoimmune bullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation.
  Michael Kasperkiewicz, M. Yale, R Strong, Detlef Zillikens, David T. Woodley, Andreas Recke> ;Journal of the European Academy of Dermatology and Venereology. 2021 Mar 29
• 27 citations
  Updated international expert recommendations for the management of autoimmune bullous diseases during the COVID-19 pandemic.
  Michael Kasperkiewicz, Enno Schmidt, Masayuki Amagai, Janet A. Fairley, Pascal Joly, Dedee F. Murrell, Aimee S. Payne, M. Yale, Detlef Zillikens, David T. Woodley> ;Journal of the European Academy of Dermatology and Venereology. 2021 Mar 2
• 9 citations
  Therapeutic Implications of Targeting Heat Shock Protein 70 by Immunization or Antibodies in Experimental Skin Inflammation.
  Stefan Tukaj, Jagoda Mantej, Michał Sobala, Katarzyna Potrykus, Zbigniew Tukaj, Detlef Zillikens, Ralf Ludwig, Katja Bieber, Michael Kasperkiewicz> ;Frontiers in Immunology. 2021 Feb 23
• 27 citations
  COVID-19 outbreak and autoimmune bullous diseases: A systematic review of published cases.
  Michael Kasperkiewicz> ;Journal of the American Academy of Dermatology. 2021 Feb 1
• 10 citations
  Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris
  Nancy Ernst, M. Friedrich, Katja Bieber, Michael Kasperkiewicz, Natalie Gross, Christian D. Sadik, Detlef Zillikens, Enno Schmidt, Ralf Ludwig, Karin Hartmann> ;Journal of the European Academy of Dermatology and Venereology. 2021 Feb 1
• 15 citations
  Case Report: Circulating Anti-SARS-CoV-2 Antibodies Do Not Cross-React With Pemphigus or Pemphigoid Autoantigens.
  Michael Kasperkiewicz, Marta Bednarek, Stefan Tukaj> ;Frontiers in Medicine. 2021 Jan 1
• Join now to see all